An Epidemic in the Midst of a Pandemic

Opioid Use Disorder and COVID-19

G. Caleb Alexander, Kenneth B. Stoller, Rebecca Lee Haffajee, Brendan Saloner

ResearchPosted on rand.org Apr 29, 2020Published in: Annals of Internal Medicine (April 2020). doi: 10.7326/M20-1141

The COVID-19 pandemic strikes at a moment when our national response to the opioid crisis was beginning to coalesce, with more persons gaining access to treatment and more patients receiving effective medications. COVID-19 threatens to dramatically overshadow and reverse this progress. Some disruptions in the care of patients with opioid use disorder are inevitable during the weeks and months to come. However, extraordinary planning and support can limit excessive disruption and its dire consequences.

Read More

Topics

Document Details

  • Copyright: American College of Physicians
  • Availability: Non-RAND
  • Year: 2020
  • Pages: 3
  • Document Number: EP-68140

Research conducted by

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.